ReaMetrix was formed to deliver high value assay solutions for applications in cellular biology using an economically attractive offshore development and manufacturing model. While a wide range of instrumentation technologies exist to address cell function, the development of reagents and assays utilizing these technologies has not kept pace. ReaMetrix uses cost efficient resources in India to develop high-value reagents that address unmet needs in the rapidly expanding field of cell function assays. The cost efficiency of the business model enables ReaMetrix to generate reagents and reagent combinations with a high degree of standardization and validation. As a result, ReaMetrix research products are differentiated within the biotechnology and pharmaceutical market segments, enabling the development of immunodiagnostic products as the business grows.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 09/30/07 | Series A | 4.75M | Unknown |